Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02204072
Title BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Xentuzumab

Age Groups: adult
Covered Countries USA | ESP


No variant requirements are available.